middle.news
Neurizon Secures Exclusive Global License to Fast-Track NUZ-001 for ALS
8:57am on Wednesday 2nd of July, 2025 AEST
•
Biotechnology
Read Story
Neurizon Secures Exclusive Global License to Fast-Track NUZ-001 for ALS
8:57am on Wednesday 2nd of July, 2025 AEST
Key Points
Exclusive global license agreement with Elanco for monepantel
Access to extensive non-clinical studies and manufacturing data
Nominal upfront fee with milestone payments up to US$79.95 million
Tiered royalties on future global net sales
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NEURIZON THERAPEUTICS (ASX:NUZ)
OPEN ARTICLE